全文获取类型
| 收费全文 | 85148篇 |
| 免费 | 5959篇 |
| 国内免费 | 242篇 |
专业分类
| 耳鼻咽喉 | 650篇 |
| 儿科学 | 2412篇 |
| 妇产科学 | 1500篇 |
| 基础医学 | 11730篇 |
| 口腔科学 | 1851篇 |
| 临床医学 | 8968篇 |
| 内科学 | 17987篇 |
| 皮肤病学 | 1221篇 |
| 神经病学 | 7835篇 |
| 特种医学 | 2850篇 |
| 外国民族医学 | 18篇 |
| 外科学 | 11820篇 |
| 综合类 | 1007篇 |
| 一般理论 | 78篇 |
| 预防医学 | 7675篇 |
| 眼科学 | 1909篇 |
| 药学 | 5805篇 |
| 1篇 | |
| 中国医学 | 100篇 |
| 肿瘤学 | 5932篇 |
出版年
| 2023年 | 441篇 |
| 2022年 | 592篇 |
| 2021年 | 1562篇 |
| 2020年 | 957篇 |
| 2019年 | 1550篇 |
| 2018年 | 1901篇 |
| 2017年 | 1388篇 |
| 2016年 | 1587篇 |
| 2015年 | 1832篇 |
| 2014年 | 2684篇 |
| 2013年 | 3645篇 |
| 2012年 | 5835篇 |
| 2011年 | 5948篇 |
| 2010年 | 3340篇 |
| 2009年 | 3011篇 |
| 2008年 | 5443篇 |
| 2007年 | 5885篇 |
| 2006年 | 5806篇 |
| 2005年 | 5506篇 |
| 2004年 | 5289篇 |
| 2003年 | 4852篇 |
| 2002年 | 4705篇 |
| 2001年 | 1079篇 |
| 2000年 | 949篇 |
| 1999年 | 1118篇 |
| 1998年 | 1083篇 |
| 1997年 | 908篇 |
| 1996年 | 786篇 |
| 1995年 | 730篇 |
| 1994年 | 602篇 |
| 1993年 | 576篇 |
| 1992年 | 704篇 |
| 1991年 | 611篇 |
| 1990年 | 549篇 |
| 1989年 | 500篇 |
| 1988年 | 525篇 |
| 1987年 | 438篇 |
| 1986年 | 485篇 |
| 1985年 | 469篇 |
| 1984年 | 492篇 |
| 1983年 | 495篇 |
| 1982年 | 479篇 |
| 1981年 | 462篇 |
| 1980年 | 441篇 |
| 1979年 | 347篇 |
| 1978年 | 349篇 |
| 1977年 | 286篇 |
| 1976年 | 209篇 |
| 1974年 | 210篇 |
| 1973年 | 205篇 |
排序方式： 共有10000条查询结果，搜索用时 15 毫秒
1.
2.
3.
4.
5.
6.
7.
Interaction effects between the 5‐hydroxy tryptamine transporter‐linked polymorphic region (5‐HTTLPR) genotype and family conflict on adolescent alcohol use and misuse 
下载免费PDF全文
下载免费PDF全文 8.
9.
Anand Dayama Nikolaos Tsilimparis Stephen Kolakowski Nathaniel M. Matolo Misty D. Humphries 《Journal of vascular surgery》2019,69(1):156-163.e1
Background
Chronic limb-threatening ischemia (CLTI), defined as ischemic rest pain or tissue loss secondary to arterial insufficiency, is caused by multilevel arterial disease with frequent, severe infrageniculate disease. The rise in CLTI is in part the result of increasing worldwide prevalence of diabetes, renal insufficiency, and advanced aging of the population. The aim of this study was to compare a bypass-first with an endovascular-first revascularization strategy in patients with CLTI due to infrageniculate arterial disease.Methods
We reviewed the American College of Surgeons National Surgical Quality Improvement Program targeted lower extremity revascularization database from 2012 to 2015 to identify patients with CLTI and isolated infrageniculate arterial disease who underwent primary infrageniculate bypass or endovascular intervention. We excluded patients with a history of ipsilateral revascularization and proximal interventions. The end points were major adverse limb event (MALE), major adverse cardiovascular event (MACE), amputation at 30 days, reintervention, patency, and mortality. Multivariable logistic regression was used to determine the association of a bypass-first or an endovascular-first intervention with outcomes.Results
There were 1355 CLTI patients undergoing first-time revascularization to the infrageniculate arteries (821 endovascular-first revascularizations and 534 bypass-first revascularizations) identified. There was no significant difference in adjusted rate of 30-day MALE in the bypass-first vs endovascular-first revascularization cohort (9% vs 11.2%; odds ratio [OR], 0.73; 95% confidence interval [CI], 0.50-1.08). However, the incidence of transtibial or proximal amputation was lower in the bypass-first cohort (4.3% vs 7.4%; OR, 0.60; CI, 0.36-0.98). Patients with bypass-first revascularization had higher wound complication rates (9.7% vs 3.7%; OR, 2.75; CI, 1.71-4.42) compared with patients in the endovascular-first cohort. Compared with the endovascular-first cohort, the incidence of 30-day MACE was significantly higher in bypass-first patients (6.9% vs 2.6%; adjusted OR, 3.88; CI, 2.18-6.88), and 30-day mortality rates were 3.23% vs 1.8% (adjusted OR, 2.77; CI, 1.26-6.11). There was no difference in 30-day untreated loss of patency, reintervention of treated arterial segment, readmissions, and reoperations between the two cohorts. In subgroup analysis after exclusion of dialysis patients, there was also no significant difference in MALE or amputation between the bypass-first and endovascular-first cohorts.Conclusions
CLTI patients with isolated infrageniculate arterial disease treated by a bypass-first approach have a significantly lower 30-day amputation. However, this benefit was not observed when dialysis patients were excluded. The bypass-first cohort had a higher incidence of MACE compared with an endovascular-first strategy. These results reaffirm the need for randomized controlled trials, such as the Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL-2) trial and Best Endovascular vs Best Surgical Therapy in Patients with Critical Limb Ischemia (BEST-CLI), to provide level 1 evidence for the role of endovascular-first vs bypass-first revascularization strategies in the treatment of this population of challenging patients. 相似文献10.
Pulmonary hamartomas are usually an incidental finding and range in size from 1 cm to 8 cm in diameter in various series. We report a case of a massive pulmonary hamartoma (size 25.5 × 17.5 × 6.5 cm and weighing 1134 g) in a 61 year old male who presented with a short history of breathlessness. The tumour was arising from the medial border of the right lung and occupying most of the right chest extending in to the anterior mediastinum. The tumour was compressing the right lung and there was no evidence of infiltration into the surrounding structures. It was successfully treated by surgical resection and final histology was pulmonary hamartoma with predominantly adipose and leiomyomatous differentiation. 相似文献